地拉罗司是治什么的？

Indications: 1. Patients with chronic iron overload and transfusion hemosiderinosis secondary to blood transfusion who are 2 years old or older will have symptoms of chronic iron overload when serum ferritin continues to be >1000 L. At this time, iron chelation therapy should be started. 2. Iron chelators can also be given to patients undergoing ASCT treatment when iron overload occurs; 3. It can be used to treat reversible renal insufficiency caused by Fanconi syndrome.

The main component of Deferasirox dispersible tablets is deferasirox. Deferasirox dispersible tablets are used to treat chronic iron overload in patients with β-thalassemia older than 6 years old due to frequent blood transfusions (monthly administration of concentrated red blood cells ≥ 7 mL/kg). For iron overload caused by children under 6 years old and other transfusion-dependent diseases, it is recommended to use with caution based on the specific conditions of the patient.

Deferasirox may cause a rash. Generally, the rash will disappear automatically without the need to adjust the dose or stop taking the medication. If the condition is severe or persistent, the medication should be stopped. The patient's vision or hearing may be affected. It should be taken 30 minutes before meals; it should be taken at Take it at the same time every day; Deferasirox dispersible tablets must not be taken with aluminum-containing antacids. The dosage (mg/kg) needs to be calculated and rounded to the nearest whole tablet; the drug must be mixed with a small amount of water, apple juice or orange juice before taking. It is not recommended to dissolve in carbonated drinks and milk, because it will cause foam and delay the dispersion speed; if you are using other drugs, please consult your physician or pharmacist before using this product; if used with other drugs at the same time, drug interactions may occur, please consult your physician or pharmacist for details.

The above is an introduction to the indications. For more information about deferasirox, please contact Medical Companion Travel for details.